药品包装信息内容和平面设计的当前要求

L. I. Mit’kina, Anastasiya K. Ericheva
{"title":"药品包装信息内容和平面设计的当前要求","authors":"L. I. Mit’kina, Anastasiya K. Ericheva","doi":"10.30895/1991-2919-2019-9-2-108-117","DOIUrl":null,"url":null,"abstract":"Labeling is an important source of information about a medicinal product. The completeness and accuracy of labeling ensures correct identification, as well as safe and efficacious use of the product. The aim of the present paper was to perform comparative analysis of requirements for the design of medicinal product packages currently applicable in the Russian Federation and in the Eurasian Economic Union (EEU) in order to facilitate the introduction of Russian medicinal products into the EEU market. The EEU requirements for medicinal product labeling are described in laws and regulations stipulating medicinal products circulation in the EEU. The Russian requirements are laid out in Federal Law No. 61-FZ «On medicines circulation» dated April 12, 2010, the State Pharmacopoeia of the Russian Federation, and the Guideline on Medicinal Products Evaluation of the FSBI «SCEEMP» of the Ministry of Health of Russia. It was demonstrated that labeling requirements described in the EEU and Russian regulations largely overlap, but there are also a number of differences that are mainly related to the information on the medicinal product composition and different interpretation of the term «herbal medicinal product». A successful promotion of Russian medicines in the EEU market will require harmonisation of definitions and requirements used in the Russian legislation with those stipulated in the EEU regulations.","PeriodicalId":22286,"journal":{"name":"The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Current Requirements for Information Content and Graphic Design of a Medicinal Product Package\",\"authors\":\"L. I. Mit’kina, Anastasiya K. Ericheva\",\"doi\":\"10.30895/1991-2919-2019-9-2-108-117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Labeling is an important source of information about a medicinal product. The completeness and accuracy of labeling ensures correct identification, as well as safe and efficacious use of the product. The aim of the present paper was to perform comparative analysis of requirements for the design of medicinal product packages currently applicable in the Russian Federation and in the Eurasian Economic Union (EEU) in order to facilitate the introduction of Russian medicinal products into the EEU market. The EEU requirements for medicinal product labeling are described in laws and regulations stipulating medicinal products circulation in the EEU. The Russian requirements are laid out in Federal Law No. 61-FZ «On medicines circulation» dated April 12, 2010, the State Pharmacopoeia of the Russian Federation, and the Guideline on Medicinal Products Evaluation of the FSBI «SCEEMP» of the Ministry of Health of Russia. It was demonstrated that labeling requirements described in the EEU and Russian regulations largely overlap, but there are also a number of differences that are mainly related to the information on the medicinal product composition and different interpretation of the term «herbal medicinal product». A successful promotion of Russian medicines in the EEU market will require harmonisation of definitions and requirements used in the Russian legislation with those stipulated in the EEU regulations.\",\"PeriodicalId\":22286,\"journal\":{\"name\":\"The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30895/1991-2919-2019-9-2-108-117\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30895/1991-2919-2019-9-2-108-117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

标签是药品信息的重要来源。标签的完整性和准确性确保了正确识别,以及产品的安全有效使用。本论文的目的是对目前适用于俄罗斯联邦和欧亚经济联盟(EEU)的医药产品包装设计要求进行比较分析,以促进俄罗斯医药产品进入欧亚经济联盟市场。欧洲经济区对药品标识的要求在规定药品在欧洲经济区流通的法律法规中进行描述。俄罗斯的要求在2010年4月12日颁布的第61-FZ号《关于药品流通》联邦法、俄罗斯联邦国家药典和俄罗斯卫生部FSBI«SCEEMP»药品评价指南中有所规定。结果表明,EEU和俄罗斯法规中描述的标签要求在很大程度上重叠,但也存在一些差异,这些差异主要与药品成分信息和“草药产品”一词的不同解释有关。俄罗斯药品在欧亚经济联盟市场上的成功推广需要将俄罗斯立法中使用的定义和要求与欧亚经济联盟条例中规定的定义和要求协调一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Current Requirements for Information Content and Graphic Design of a Medicinal Product Package
Labeling is an important source of information about a medicinal product. The completeness and accuracy of labeling ensures correct identification, as well as safe and efficacious use of the product. The aim of the present paper was to perform comparative analysis of requirements for the design of medicinal product packages currently applicable in the Russian Federation and in the Eurasian Economic Union (EEU) in order to facilitate the introduction of Russian medicinal products into the EEU market. The EEU requirements for medicinal product labeling are described in laws and regulations stipulating medicinal products circulation in the EEU. The Russian requirements are laid out in Federal Law No. 61-FZ «On medicines circulation» dated April 12, 2010, the State Pharmacopoeia of the Russian Federation, and the Guideline on Medicinal Products Evaluation of the FSBI «SCEEMP» of the Ministry of Health of Russia. It was demonstrated that labeling requirements described in the EEU and Russian regulations largely overlap, but there are also a number of differences that are mainly related to the information on the medicinal product composition and different interpretation of the term «herbal medicinal product». A successful promotion of Russian medicines in the EEU market will require harmonisation of definitions and requirements used in the Russian legislation with those stipulated in the EEU regulations.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analysis of the Medicinal Products for Human Use Authorised in the Russian Federation Diffusion-Ordered NMR Spectroscopy Application for Analysis of Polysaccharides Determination of Heavy Metals, Arsenic, and Aluminum Content in Pumpkin Seed Herbal Substance and Native Products, by Inductively Coupled Plasma Mass Spectrometry The Use of Spectroscopic Methods for Structural Elucidation of Individual Secondary Metabolites Isolated from the Aerial Parts of Corydalis bracteata NMR as Used in the Russian and Foreign Pharmacopoeias for Quality Control of Medicinal Products
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1